LAXA
Food supplement declared in France, declaration No 2017-8-29, decision dated 1 August 2017
LAXA is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). 2 points in its composition require a check (prohibited substance, dose or novel food). 2 rules of use apply to its ingredients (limits and warnings).
- Brand
- not provided
- Food business operator placing the product on the market
- NTB
- Status
- Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
- Form
- Comprimé
- Daily dose
- 3 comprimés
- Directions for use
- Avaler 1 comprimé matin, midi et soir avec un peu d’eau pendant les repas
- Intended populations
- Homme, Femme
- Not recommended for (according to the manufacturer)
- Femmes allaitantes, Enfants (moins de 12 ans), Femmes enceintes, Utilisation prolongée
- Objectives stated by the manufacturer (these are not authorised claims)
- Transit
Declaration 282712, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
Regulatory points
- À vérifier
Contains a preparation of alder buckthorn (Rhamnus frangula) (ecorce). Preparations from this plant part containing hydroxyanthracene derivatives are under Union scrutiny (Annex III, Part C): a draft regulation sent to the Council on 15 July 2026 would prohibit them, with 12 months to sell through products already on the market. Their content is not declared.
Source: Regulation (EC) No 1925/2006, latest consolidated version, annexe III, partie C (règlement (UE) 2021/468) ; projet de la Commission D099926/3.
- À vérifier
Contains a preparation of rhubarb (Rheum officinale) (racine). Preparations from this plant part containing hydroxyanthracene derivatives are under Union scrutiny (Annex III, Part C): a draft regulation sent to the Council on 15 July 2026 would prohibit them, with 12 months to sell through products already on the market. Their content is not declared.
Source: Regulation (EC) No 1925/2006, latest consolidated version, annexe III, partie C (règlement (UE) 2021/468) ; projet de la Commission D099926/3.
- Conditions légales
Frangula dodonei Ard.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux enfants de moins de 12 ans, aux femmes enceintes et allaitantes ainsi qu'une mention déconseillant l'usage prolongé.
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
- Conditions légales
Rheum officinale Baill.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux enfants de moins de 12 ans, aux femmes enceintes et allaitantes et une mention déconseillant l'usage prolongé.
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Fucus vesiculosus L. | Thalle | Poudre (de plantes séchées ou broyées) | 150 mg |
| Rheum officinale Baill. | Racine | Poudre (de plantes séchées ou broyées) | 150 mg |
| Peumus boldus Molina | Feuille | Extrait sec aqueux | 75 mg |
| Frangula dodonei Ard. | Ecorce | Extrait sec aqueux | 45 mg |
Vitamins and minerals
Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).
| Declared form | Nutrient | EFSA limit, adults | Maximum dose in France |
|---|---|---|---|
| Acétate de DL-alpha-tocophéryle | Vitamine E | 300 mg | 30 mg |
Additives
E420, E468, E470b
Other ingredients
lactose
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
List recorded in 2017. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.
Label warnings
En lien avec le réglement INCO, l'allergène lactose est mis en avant dans la liste des ingrédients.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.